by Romain Magnez | May 16, 2026 | Publications
We’re proud to share our latest publication in MDPI Animals: “Safety, Immunogenicity, and Vaccine Compatibility of a Trivalent Inactivated In Ovo Nanovaccine Against Avian Colibacillosis in Broilers.”This is the first report of an inactivated in ovo vaccine against...
by Romain Magnez | Oct 20, 2025 | Publications
We’re thrilled to announce our latest publication, developed in collaboration with 20 leading zoos worldwide, presenting a nasal vaccine candidate against Toxoplasma gondii. Link to the publicationThis strategic research not only exemplifies cross-sector...
by Romain Magnez | Oct 16, 2025 | News
We are proud to announce that Vaxinano has been selected as a winner of the INOV State Innovation Competition and is among the projects supported under #France2030! A huge thank you to the French Government, ADEME, and Bpifrance for their trust and support through...
by Romain Magnez | Sep 26, 2025 | News
Honored that Didier Betbeder, our CSO, was invited to present the Vaxinano mucosal vaccine platform at the Conference: Harnessing airway immunity for next-gen vaccines, organized by the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) Nordisk...
by Romain Magnez | May 10, 2025 | News
Vaxinano Wins the “Impact” Award at Tech For Future by La Tribune and BNP Paribas We are proud to announce that Vaxinano has been awarded the “Impact” Prize at the prestigious Tech For Future event, organized by La Tribune in partnership with...
